Animal
Model Market, by Species Type (Rodents (Rats, Mouse, Guinea Pigs and
Woodchuck), Rabbits, Monkeys, and Other Species), by Application (Toxicology
Studies, Drug Discovery and Development, Basic and Applied Research, and
Others), by End Users (Academic & Research Institutions, Contract Research
Organizations (CROs), and Pharmaceutical companies), and by Region (North
America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size,
Share, Outlook, and Opportunity Analysis 2018 – 2026
Most of the biomedical researches
are carried on animal model with short-term objective to study toxicity of
drugs for developing new therapeutics for certain diseases. The main objective
of using animal model in research is to determine how the animal will respond
to the treatment. The anatomical and physiological similarities between humans
and animals help the researchers to investigate novel therapies in animal models
before applying it on humans. The use of animal model in research is based on
fact that human diseases can affect other animal species. It is not only
limited for infectious diseases but also for common diseased conditions
including diabetes, hypertension, cancer, epilepsy, and others.
Animal Model Market Outlook
Increasing number of research
based on animal test to develop novel drugs is a major factor that boosts the
animal model market growth. For instance, as per data reported in Annual
Statistics of Scientific Procedures on Living Animals, about 3.79 million
scientific procedures were carried out on protected living animals in Great
Britain in 2017.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2488
Moreover, as per data in
Worldwide Animal Research Statistics, in 2016, 3,789,373 vertebrates per
procedure and 110,553 mammals per procedure (excluding rats and mice) have been
used in research experiments conducted in the U.S.
However, rising concern for
animal welfare by social and government organizations leads to use lesser
number of animals in research purpose, which may hamper growth of the animal
model market.
Animal Model Market Regional
Analysis
On the basis of region, the
global animal model market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America is
expected to witness conducive growth for animal model market, owing to high
presence of major market players in this region. For instance, in September
2018, Taconic Biosciences, a U.S. based company providing genetically
engineered rodent model solutions, announced partnership plans with Government
Scientific Source (GSS) to become the first animal model provider on general
services administration contract schedule. Taconic Bioscience’s products are
fit into GSS effort to support biomedical research solutions within the U.S.
federal government.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/animal-model-market-2488
Moreover, in November 2018,
Jackson Laboratory, an independent, nonprofit biomedical research institution
headquartered in Maine, the U.S., established a dedicated quarantine facility
for the importation of JAX Mice into China. Thus, expansion of facilities by
manufacturers in Asia Pacific is expected to show high growth of the market
during the forecast period.
Increasing use of animal models
in research for developing vaccines is another major factor, which will show
significant growth for animal model market in Europe. For instance, in November
2018, in the workshop organized by EDUFLUVAC consortium, a European Union
funded project, coordinated by the European Vaccine Initiative, experts from
influenza vaccine community gathered to discuss the current knowledge and
future perspectives for testing broadly reactive influenza vaccines in animal
models. The workshop has been organized for summarizing the outcome of
“Experimental animal models for universal influenza vaccines” project.
Key players in the animal model
market include Charles River Laboratories International, Inc., Horizon
Discovery Group plc, The Jackson Laboratory, Trans Genic Inc, Taconic
Biosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc.,
Harbour Antibodies BV, Envigo CRS SA, Ingenious Targeting Laboratory, and
Transposagen Biopharmaceuticals, Inc.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2488
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment